Using the medication for weight loss without type 2 diabetes may not qualify
Men exploring peptide therapy for GH optimization often have overlapping concerns about testosterone, and the two systems interact meaningfully: testosterone supports lean mass and anabolic signaling, while GH and IGF-1 support fat metabolism, recovery, and tissue repair through distinct but complementary pathways
It is not approved as a pharmaceutical or supplement in EU/US
If the patient is unable to hold the GLP-1 receptor agonist for at least 3 half-lives before the procedure, consider rapid-sequence induction of general anesthesia, to reduce the risk of aspiration, and consider the use of point-of-care gastric ultrasonography, where available, to check for residual gastric content
There have also been reports of gallbladder problems , including cholelithiasis (gallstones) and cholecystitis, particularly in patients experiencing rapid weight loss
Previously, there had only been one oral drug for this indication: metformin, which was approved in 2000